U.S. Markets close in 1 hr 4 mins

What’s Expected of Novartis’s Core Operating Income in 2018?

Margaret Patrick
What’s Expected of Novartis’s Core Operating Income in 2018?

Novartis (NVS) has projected that its fiscal 2018 core operating income will be higher by mid- to high-single digits on a YoY (year-over-year) basis. The company expects core operating income, however, to remain flat or only rise by low-single digits on a YoY basis in 1H18. While the company has projected robust growth trends for its IM (Innovative Medicines) and Alcon segments, Novartis expects to witness increasing pricing pressures in the US in its Sandoz segment.